مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: "Metabolic reprogramming" in ovarian cancer cells resistant to cisplatin.
Normal view MARC view ISBD view

"Metabolic reprogramming" in ovarian cancer cells resistant to cisplatin. [electronic resource]

By:
  • Montopoli, M
Contributor(s):
  • Bellanda, M
  • Lonardoni, F
  • Ragazzi, E
  • Dorigo, P
  • Froldi, G
  • Mammi, S
  • Caparrotta, L
Producer: 20110516Description: 226-35 p. digitalISSN:
  • 1873-5576
Subject(s):
  • Antineoplastic Agents -- metabolism
  • Apoptosis -- drug effects
  • Carcinoma -- drug therapy
  • Cell Line, Tumor
  • Cisplatin -- metabolism
  • Cytoplasmic Granules -- drug effects
  • DNA, Mitochondrial -- genetics
  • Drug Resistance, Neoplasm
  • Female
  • Glucose -- metabolism
  • Glutathione -- metabolism
  • Humans
  • Inhibitory Concentration 50
  • Lipid Metabolism -- drug effects
  • Membrane Potential, Mitochondrial -- drug effects
  • Mitochondria -- drug effects
  • Oligomycins -- pharmacology
  • Ovarian Neoplasms -- drug therapy
  • Oxidative Phosphorylation -- drug effects
  • Oxygen Consumption -- drug effects
  • Rotenone -- pharmacology
  • Uncoupling Agents -- pharmacology
Online resources:
  • Available from publisher's website
In: Current cancer drug targets vol. 11
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

Log in to your account to post a comment.

"Metabolic reprogramming" in ovarian cancer cells resistant to cisplatin.

APA

Montopoli M., Bellanda M., Lonardoni F., Ragazzi E., Dorigo P., Froldi G., Mammi S. & Caparrotta L. (20110516). "Metabolic reprogramming" in ovarian cancer cells resistant to cisplatin. : Current cancer drug targets.

Chicago

Montopoli M, Bellanda M, Lonardoni F, Ragazzi E, Dorigo P, Froldi G, Mammi S and Caparrotta L. 20110516. "Metabolic reprogramming" in ovarian cancer cells resistant to cisplatin. : Current cancer drug targets.

Harvard

Montopoli M., Bellanda M., Lonardoni F., Ragazzi E., Dorigo P., Froldi G., Mammi S. and Caparrotta L. (20110516). "Metabolic reprogramming" in ovarian cancer cells resistant to cisplatin. : Current cancer drug targets.

MLA

Montopoli M, Bellanda M, Lonardoni F, Ragazzi E, Dorigo P, Froldi G, Mammi S and Caparrotta L. "Metabolic reprogramming" in ovarian cancer cells resistant to cisplatin. : Current cancer drug targets. 20110516.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site